Cart

News & Science

May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?

May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?

2021-01-18

Omega-3 long-chain polyunsaturated fatty acids (omega-3 LC-PUFAs) could help improve the resolution of the inflammatory balance, limiting therefore the level and duration of the critical inflammatory period. Omega-3 LC-PUFAs may also interact at different stages of the viral infection, notably on the virus entry and replication.
Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study

Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study

2020-11-30

The findings showed that DPA as a reservoir could be metabolized into DHA, and further retro-conversed back to EPA. Supplementation with EPA was efficiently incorporated into plasma lipid fractions, whereas incorporation of DHA into plasma lipid fractions was limited within a short period of supplement.
Effect of omega-3 supplementation on neuropathy in type 1 diabetes - A 12-month pilot trial

Effect of omega-3 supplementation on neuropathy in type 1 diabetes - A 12-month pilot trial

2020-10-28

12 months of seal oil omega-3 polyunsaturated fatty acids (v-3 PUFA) supplementation will stop the known progression of diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes mellitus (T1DM).
Association between Obesity and Omega-3 Status in Healthy Young Women

Association between Obesity and Omega-3 Status in Healthy Young Women

2020-10-01

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are essential for healthy development and protect against metabolic disease. However, individuals with obesity may be pre-disposed to experiencing lower n-3 PUFA status than normal-weight individuals.

Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus

Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus

2020-09-04

Preclinical and clinical studies reveal that consumption of the marine ω-3 highly unsaturated fatty acids (HUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) might be used as a precision nutrition intervention to lessen lupus symptoms. 
Higher levels of omega-3s are associated with lower risk of suboptimal sleep

Higher levels of omega-3s are associated with lower risk of suboptimal sleep

2020-08-04

Research: participant ages ranged from 35 to 96 years from 5 countries (Finland, Iceland, Sweden, Singapore, and the United States) with higher circulating omega-3 FAs had a lower risk of suboptimal sleep.

Potential benefits of omega-3 supplementation to patients with COVID-19

Potential benefits of omega-3 supplementation to patients with COVID-19

2020-07-16

Omega-3 dietary supplements could possibly improve the COVID-19 patient's recovery. Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), present an anti-inflammatory effect that could ameliorate some patients need for intensive care unit (ICU) admission
Long-chain omega-3 polyunsaturated fatty acids and healthy ageing

Long-chain omega-3 polyunsaturated fatty acids and healthy ageing

2020-06-26

A study published in the British Medical Journal found an association between higher blood levels of the long-chain omega-3 fatty acids EPA, DPA, and DHA and “healthy aging.” The authors concluded their findings support guidelines for increased dietary consumption of long-chain omega-3s in older adults.
Omega-3 significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum

Omega-3 significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum

2020-06-19

Omega-3 FA significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum and well-tolerated. Furthermore, the omega-3 response was linked to higher EPA proportion in omega-3 formula and mild- to-moderate depression.
Powered by Shopify